Amy Abernethy
CIK 1590728 · last filed 2023-11-09
Amy Abernethy is a corporate insider who has filed 21 SEC Form 4 insider transactions across 3 companies since 2013. The most recent filing, for EQRXW, was dated Nov 9, 2023. Across all open-market trades the lifetime net is −$525.6K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.1M across reported positions. 12 SEC filings were submitted jointly with ATHENAHEALTH INC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ATHN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
WATERTOWN, MA 02472
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EQRx, Inc. (EQRXW) Delisted | Director | 0 | $0.05 | $0 | $0 | 6 | 2023-11-09 |
| CDNA | Director | 15,837 | $69.10 | $1.09M | $0 | 4 | 2019-01-23 |
| ATHENAHEALTH INC (ATHN) Delisted | Director | 5,976 | $9.59 | $57.3K | -$525.6K | 11 | 2018-06-08 |
Recent Filings
21 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-11-09 | EQRx, Inc. (EQRXW) Delisted | Disp (D) | −200,000 | $0 | EDGAR |
| 2023-02-22 | EQRx, Inc. (EQRXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-02-22 | EQRx, Inc. (EQRXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-10-04 | EQRx, Inc. (EQRXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-03-01 | EQRx, Inc. (EQRXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-21 | EQRx, Inc. (EQRXW) Delisted | Mixed | +200,000 | $0 | EDGAR |
| 2019-01-23 | CDNA | Exer (M) | +5,000 | $64.4K | EDGAR |
| 2019-01-03 | CDNA | Grant (A) | +437 | $0 | EDGAR |
| 2018-10-02 | CDNA | Grant (A) | +400 | $0 | EDGAR |
| 2018-07-03 | CDNA | Grant (A) | +10,000 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.